about
Suggested guidelines for the diagnosis and management of urea cycle disordersInterphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosisClinical and experimental applications of sodium phenylbutyrateHistone deacetylases--a new target for suppression of cartilage degradation?Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectivesThe Prodrug Approach: A Successful Tool for Improving Drug SolubilityComplex structure of a bacterial class 2 histone deacetylase homologue with a trifluoromethylketone inhibitorAggresome formation and neurodegenerative diseases: therapeutic implicationsDimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drugExploration of Novel Inhibitors for Class I Histone Deacetylase Isoforms by QSAR Modeling and Molecular Dynamics Simulation AssaysHistone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteinsProlonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse modelProliferation control strategies to improve productivity and survival during CHO based production culture : A summary of recent methods employed and the effects of proliferation control in product secreting CHO cell linesModulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectivesNatural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1).Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism.Calcium butyrate: Anti-inflammatory effect on experimental colitis in rats and antitumor propertiesAnti-tumor effect in human lung cancer by a combination treatment of novel histone deacetylase inhibitors: SL142 or SL325 and retinoic acids.Inhibition of STAT3 acetylation is associated with angiotesin renal fibrosis in the obstructed kidney.Histones: Controlling Tumor Signaling CircuitryHistone deacetylases and mood disorders: epigenetic programming in gene-environment interactionsMYB suppresses differentiation and apoptosis of human breast cancer cells.3-Hydroxypyridin-2-thione as novel zinc binding group for selective histone deacetylase inhibition.Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell linePre-mRNA splicing is a determinant of nucleosome organizationLigand Based Pharmacophore Modeling and Virtual Screening Studies to Design Novel HDAC2 Inhibitors.The Histone Deacetylase Inhibitor Trichostatin A Sensitizes Human Renal Carcinoma Cells to TRAIL-Induced Apoptosis through Down-Regulation of c-FLIPL.HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis.Genome-wide histone acetylation profiling of Herpesvirus saimiri in human T cells upon induction with a histone deacetylase inhibitor.Epigenetic therapy for breast cancer.Drug discovery from natural sources.Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosisRegulation of immune responses by histone deacetylase inhibitorsCharacterization of a gene cluster responsible for the biosynthesis of anticancer agent FK228 in Chromobacterium violaceum No. 968FK228 Analogues Induce Fetal Hemoglobin in Human Erythroid Progenitors.Isoform-specific up-regulation of plasma membrane Ca2+ATPase expression during colon and gastric cancer cell differentiationRepositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.Recent advances in the search for antiviral agents against human papillomaviruses.
P2860
Q21202856-7F5BB19F-AE67-413B-9745-C02E00572DBAQ24338619-CCADA9C7-25EE-4574-9161-ACF759AFB3D3Q24613511-7D5D12B0-F887-4934-8C7A-5DF4F7FCA077Q24810469-43A0516A-514B-40A3-B9E2-FC351A305241Q26744441-2566BD21-831D-4F93-9A10-4266F3F20ED4Q26771271-E333F238-0CB7-49E3-B722-F08C181CFBA9Q27644313-3099D754-765C-4E24-993D-855523CFB435Q28265926-E9BD924A-D548-4D01-A3F1-6D43E1A69773Q28282479-0A3CB85D-CA70-4510-BEC7-B478017DE16AQ28550025-136464A1-A2F0-4AF5-BBF8-D3A88A30990AQ28571005-1A85D368-0A93-4F2A-A9FB-5CDD9FB4532EQ28743986-A0C3546E-D53C-4E43-8CDB-A5447FA7B376Q30492978-439FDEA3-FDCC-4ADE-9050-11DAE4A469A2Q30570945-C650227D-EDD6-4BF8-9B9A-F0BF443A519DQ33235403-1D4BE342-A395-4FD6-BA8B-6AFB2D4AE3BEQ33236503-C8FB4943-A64D-4D21-877D-9459492A828BQ33380457-95F6EFE7-48C6-4E65-A68C-AD3C31C90B27Q33733474-3EEDC7CC-12AF-44C9-B8AC-636057FDC6DDQ33747841-8929B581-8AF9-4FBF-8188-47DBD4F7184FQ34017974-62072CB3-C509-4FC4-82CB-AC91D38781B3Q34109472-C9AC0EF3-1958-4B0A-AC8E-527A2BC70691Q34144718-E2C8A407-B0C7-4136-BEDA-9C1426EE14A4Q34173485-39F92B15-F9C6-4640-9B0C-A941FCE4EE70Q34336500-CE67299C-5A5B-430A-BF74-02ADD33A357CQ34366588-B5C70FD8-9417-4D39-AB14-71E890B0513DQ34551455-B47EB276-0E4D-48BD-A8F6-13F455989610Q34695894-D2CF6C6B-E1AD-42A5-8B6C-24C622DFD13CQ34865077-709BF071-8D72-4DC3-9641-952BAB1A2D87Q34885424-65E1C30A-A3D8-42EC-9974-F4114F7961BDQ34982689-6E4318AD-939B-4B32-AA38-F34BE7E17A12Q35162148-F27F4674-CF63-476A-8853-A5DFC2580AD4Q35594873-1F043E57-DECF-44C3-99F0-790FB7008330Q35617209-CFA3EB81-1C7C-467E-A411-680B302A9C36Q35637411-0D5208E1-B8FB-4AAF-8BB0-70D023A94CE6Q35855571-195E994E-0F5F-46D3-84FB-A0855C3EF589Q35913058-84AE7647-9AFE-4B2B-B102-894DAB89B2ABQ35986327-A9587EA1-77C8-4E12-83C0-8B31C27FFDE2Q36174203-3D5D1CE5-2726-46C2-8583-FB96026D970FQ36225879-A1E1E5CA-0414-4013-A202-D196E396BB66Q36284493-D7287E5C-7AFE-424C-9409-A88A421C5657
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Histone deacetylase inhibitors.
@ast
Histone deacetylase inhibitors.
@en
type
label
Histone deacetylase inhibitors.
@ast
Histone deacetylase inhibitors.
@en
prefLabel
Histone deacetylase inhibitors.
@ast
Histone deacetylase inhibitors.
@en
P1476
Histone deacetylase inhibitors.
@en
P2093
Claude Monneret
P356
10.1016/J.EJMECH.2004.10.001
P577
2005-01-01T00:00:00Z